Ethocle Reports has published its latest Market Research Report on Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.

1. Transcatheter Heart Valves - Medical DevicesPipeline Assessment,2016
Ethocle Reportshaspublished its latest MarketResearch Reporton Transcatheter Heart Valves -
Medical DevicesPipeline Assessment,2016. Formulatesignificantcompetitorinformation, analysis,and
insightsto improveR&D strategies.Browsemarketdata tablesand figures.
PublishedOn: 05-Dec-2016 | Pages: 257
Summary
GlobalData'sMedical Devicessectorreport,“TranscatheterHeartValves - Medical DevicesPipeline
Assessment,2016" providesanoverview of TranscatheterHeartValvescurrentlyinpipelinestage.
The report providescomprehensiveinformationonthe pipeline productswithcomparative analysisof
the productsat variousstagesof development.The reportreviewsmajorplayersinvolvedinthe pipeline
productdevelopment.Italsoprovidesinformationaboutclinical trialsinprogress,whichincludestrial
phase, trial status,trial start and enddates,and,the numberof trialsfor the keyTranscatheterHeart
Valvespipeline products.
Thisreportis preparedusingdatasourcedfromin-house databases,secondaryandprimaryresearchby
GlobalData'steamof industryexperts.
Click here to find out more about this report?
Scope
- Extensive coverage of the TranscatheterHeartValvesunderdevelopment
- The report reviewsdetailsof majorpipeline productswhichincludes,productdescription,licensing
and collaborationdetailsandotherdevelopmental activities
- The report reviewsthe majorplayersinvolvedinthe developmentof TranscatheterHeartValvesand
listall theirpipeline projects
- The coverage of pipeline productsbasedonvariousstagesof developmentrangingfromEarly
DevelopmenttoApproved/Issuedstage
- The report provideskeyclinical trial dataof ongoingtrialsspecifictopipeline products

2. - Recentdevelopmentsinthe segment/industry
Get Free Sample Report
Click here for Discounts
Reasons to buy
The report enablesyouto -
- Formulate significantcompetitorinformation,analysis,andinsightstoimprove R&Dstrategies
- Identifyemergingplayerswithpotentiallystrongproductportfolioandcreate effective counter-
strategiestogaincompetitiveadvantage
- Identifyandunderstandimportantanddiversetypesof TranscatheterHeartValvesunder
development
- Developmarket-entryandmarketexpansionstrategies
- Planmergersandacquisitionseffectivelybyidentifyingmajorplayerswiththe mostpromisingpipeline
- In-depthanalysisof the product’scurrentstage of development,territoryandestimatedlaunchdate
Table of Contents
1.1 Listof Tables7
1.2 Listof Figures16
2 Introduction17
2.1 TranscatheterHeartValvesOverview 17
3 ProductsunderDevelopment18
3.1 TranscatheterHeartValves - Pipeline ProductsbyStage of Development18
3.2 TranscatheterHeartValves - Pipeline ProductsbySegment19
3.3 TranscatheterHeartValves - Pipeline ProductsbyTerritory20
3.4 TranscatheterHeartValves - Pipeline ProductsbyRegulatoryPath21

3. 3.5 TranscatheterHeartValves - Pipeline ProductsbyEstimatedApproval Date 22
3.6 TranscatheterHeartValves - OngoingClinical Trials23
4 TranscatheterHeartValves - Pipeline ProductsunderDevelopmentbyCompanies24
4.1 TranscatheterHeartValvesCompanies - PipelineProductsbyStage of Development24
4.2 TranscatheterHeartValves - Pipeline ProductsbyStage of Development27
5 TranscatheterHeartValvesCompaniesandProductOverview 31
5.1 AbbottVascularInc.CompanyOverview 31
5.1.1 AbbottVascularInc.PipelineProducts&OngoingClinical TrialsOverview 31
5.2 AdmedusLtdCompanyOverview32
5.2.1 AdmedusLtdPipeline Products&OngoingClinical TrialsOverview 32
5.3 AdvancedBioProstheticSurfacesLtd.CompanyOverview34
5.3.1 AdvancedBioProstheticSurfacesLtd.Pipeline Products&OngoingClinical TrialsOverview 34
5.4 AegisSurgical LimitedCompanyOverview 35
5.4.1 AegisSurgical LimitedPipeline Products&OngoingClinical TrialsOverview 35
5.5 AnnulonCompanyOverview36
5.5.1 AnnulonPipeline Products&OngoingClinical TrialsOverview 36
5.6 AorTechInternational PlcCompanyOverview 37
5.6.1 AorTechInternational PlcPipelineProducts&OngoingClinical TrialsOverview 37
5.7 ArborSurgical Technologies,Inc.CompanyOverview 39
5.7.1 Arbor Surgical Technologies,Inc.PipelineProducts&OngoingClinicalTrialsOverview39
5.8 BostonScientificCorpCompanyOverview 40
5.8.1 BostonScientificCorpPipeline Products&OngoingClinical TrialsOverview 40
5.9 CelyadSA CompanyOverview55
5.9.1 CelyadSA Pipeline Products&OngoingClinical TrialsOverview 55
5.10 CepheaValve Technologies,Inc.CompanyOverview 57

4. 5.10.1 CepheaValve Technologies,Inc.Pipeline Products&OngoingClinical TrialsOverview 57
5.11 Children'sHospital BostonCompanyOverview 58
5.11.1 Children'sHospital BostonPipelineProducts&OngoingClinical TrialsOverview 58
5.12 ClemsonUniversityCompanyOverview 60
5.12.1 ClemsonUniversityPipeline Products&Ongoing Clinical TrialsOverview 60
5.13 Colibri HeartValve,LLCCompanyOverview 61
5.13.1 Colibri HeartValve,LLCPipelineProducts&OngoingClinical TrialsOverview61
5.14 Direct FlowMedical IncCompanyOverview 67
5.14.1 Direct FlowMedical IncPipelineProducts&OngoingClinicalTrialsOverview67
5.15 Dura LLC CompanyOverview 73
5.15.1 Dura LLC PipelineProducts&OngoingClinicalTrialsOverview73
5.16 Edwards LifesciencesCorpCompanyOverview 75
5.16.1 Edwards LifesciencesCorpPipeline Products& OngoingClinical TrialsOverview 76
5.17 Emory UniversityCompanyOverview 100
5.17.1 Emory UniversityPipeline Products&OngoingClinical TrialsOverview 100
5.18 Endoluminal TechnologyResearch,LLCCompanyOverview101
5.18.1 Endoluminal TechnologyResearch,LLCPipeline Products&OngoingClinical TrialsOverview101
5.19 HansenMedical Inc CompanyOverview 103
5.19.1 HansenMedical Inc PipelineProducts&OngoingClinicalTrialsOverview103
5.20 HighLife SASCompanyOverview105
5.20.1 HighLife SASPipeline Products&OngoingClinical TrialsOverview 105
5.21 HLT, Inc.CompanyOverview106
5.21.1 HLT, Inc. Pipeline Products&OngoingClinical TrialsOverview 106
5.22 InterVene Inc.CompanyOverview108
5.22.1 InterVene Inc.Pipeline Products&OngoingClinical TrialsOverview 108

5. 5.23 JC Medical,Inc.CompanyOverview109
5.23.1 JC Medical,Inc.PipelineProducts&OngoingClinical TrialsOverview 109
5.24 JenaValve TechnologyGmbHCompanyOverview 111
5.24.1 JenaValve TechnologyGmbHPipeline Products&OngoingClinical TrialsOverview111
5.25 Mayo ClinicUSCompanyOverview 114
5.25.1 Mayo ClinicUSPipelineProducts&OngoingClinical TrialsOverview 114
5.26 Medtronicplc CompanyOverview115
5.26.1 Medtronicplc Pipeline Products&OngoingClinical TrialsOverview 115
5.27 Meril Life SciencesPvtLtdCompanyOverview 130
5.27.1 Meril Life SciencesPvtLtd Pipeline Products&OngoingClinical TrialsOverview 130
5.28 Micro InterventionalDevices,Inc.CompanyOverview 131
5.28.1 Micro Interventional Devices,Inc.Pipeline Products&OngoingClinical TrialsOverview 131
5.29 MicroPort ScientificCorpCompanyOverview 133
5.29.1 MicroPort ScientificCorpPipeline Products&OngoingClinical TrialsOverview 133
5.30 Mitralix Ltd. CompanyOverview 135
5.30.1 Mitralix Ltd. Pipeline Products&OngoingClinical TrialsOverview 135
5.31 MitrAssistLtd.CompanyOverview136
5.31.1 MitrAssistLtd. Pipeline Products&OngoingClinical TrialsOverview 136
5.32 MValve TechnologiesLtd.CompanyOverview 137
5.32.1 MValve TechnologiesLtd.PipelineProducts&OngoingClinical TrialsOverview 137
5.33 NaviGate CardiacStructures,Inc.CompanyOverview 139
5.33.1 NaviGate CardiacStructures,Inc.PipelineProducts&OngoingClinical TrialsOverview 139
5.34 NeovascInc CompanyOverview140
5.34.1 NeovascInc Pipeline Products&OngoingClinical TrialsOverview 140
5.35 PolyNovaCardiovascularLLCCompanyOverview 143

6. 5.35.1 PolyNovaCardiovascularLLCPipelineProducts&OngoingClinical TrialsOverview 143
5.36 RegenaGraftCompanyOverview144
5.36.1 RegenaGraftPipeline Products&OngoingClinical TrialsOverview 144
5.37 SAS Cormove CompanyOverview 145
5.37.1 SAS Cormove PipelineProducts&OngoingClinicalTrialsOverview145
5.38 SinoMedical SciencesTechnologyInc.CompanyOverview 146
5.38.1 SinoMedical SciencesTechnologyInc.Pipeline Products&OngoingClinical TrialsOverview 146
5.39 St. Jude Medical IncCompanyOverview 147
5.39.1 St. Jude Medical Inc Pipeline Products&OngoingClinical Trials Overview 147
5.40 SymetisAGCompanyOverview 160
5.40.1 SymetisAGPipelineProducts&OngoingClinical TrialsOverview 160
5.41 ThubrikarAorticValve,Inc.CompanyOverview 166
5.41.1 ThubrikarAortic Valve,Inc.Pipeline Products&OngoingClinical TrialsOverview 166
5.42 UniversiteitUtrechtCompanyOverview 167
5.42.1 UniversiteitUtrechtPipeline Products&OngoingClinical TrialsOverview 167
5.43 UniversityCollege LondonCompanyOverview 168
5.43.1 UniversityCollege LondonPipelineProducts&OngoingClinical TrialsOverview168
5.44 Universityof CaliforniaSanFranciscoCompanyOverview 170
5.44.1 Universityof CaliforniaSanFranciscoPipeline Products&OngoingClinical TrialsOverview 170
5.45 Universityof Cambridge CompanyOverview 171
5.45.1 Universityof Cambridge Pipeline Products&OngoingClinical TrialsOverview 171
5.46 Universityof IowaCompanyOverview 172
5.46.1 Universityof IowaPipeline Products&OngoingClinical TrialsOverview 172
5.47 ValtechCardioLtd CompanyOverview 174
5.47.1 ValtechCardioLtd Pipeline Products&OngoingClinical TrialsOverview 174

7. 5.48 VenusMedTechCompanyOverview 175
5.48.1 VenusMedTechPipeline Products&OngoingClinical TrialsOverview 175
5.49 XeltisAGCompanyOverview 181
5.49.1 Xeltis AGPipelineProducts&OngoingClinicalTrialsOverview181
6 TranscatheterHeartValves- RecentDevelopments182
6.1 Dec 01, 2016: MedtronicAnnouncesReimbursementApproval andLaunchof CoreValve EvolutR
SysteminJapan182
6.2 Nov28, 2016: NeovascReceivesRegulatoryApproval ToInitiateTIARA IICE Mark Study183
6.3 Nov26, 2016: EdwardsLifesciencestoAcquire ValtechCardio183
6.4 Nov22, 2016: MedtronicReportsSecondQuarterFinancial Results183
6.5 Nov16, 2016: MedtronicReleasesFY16IntegratedPerformanceReport186
6.6 Nov15, 2016: CEVA to workwithMedtronicfor distributionfacilityconstruction187
6.7 Nov14, 2016: NeovascReportsThirdQuarterResultsfor2016 187
6.8 Nov03, 2016: StudyDeemsTranscaval Valve ReplacementPioneered atHenryFordHospital
‘Successful’190
6.9 Nov01, 2016: MedtronicHarmonyTranscatheterPulmonaryValve DemonstratesPositiveEarly
Clinical OutcomesAtOne Year190
6.10 Nov01, 2016: NeovascAnnouncesUpdate inLitigationwithCardiAQ191
6.11 Nov01, 2016: XeltisAnnouncesMultidisciplinaryScientificAdvisoryBoardof Global Leading
Experts192
6.12 Nov01, 2016: Early AndSustainedQualityOf Life ImprovementsSeenForIntermediateRisk
PatientsTreatedWithEdwardsTranscatheterValves192
6.13 Oct 31, 2016: NewData on MedtronicEvolutR TAVRSystemShow Excellent'Real-World'Outcomes
inGlobal PatientPopulation193
6.14 Oct 31, 2016: Newmethodforperformingaorticvalve replacementprovessuccessfulinhighrisk
patients194
6.15 Oct 27, 2016: The Successful WorldwideFirstinHumanImplantationof anInnovative AorticValve
fromColibri HeartValve andVenusMedtechwithDisruptive "DryTissue"TechnologyConducted195
6.16 Oct 26, 2016: Neovascto PresentTiaraData at TCT inWashingtonDC 196

8. 6.17 Oct 26, 2016: MedtronicAnnouncesFDA Approval of New Recaptureable TAVRSystemAvailable
for Severe AorticStenosisPatientswithLarge Anatomies196
6.18 Oct 26, 2016: BostonScientificAnnouncesResultsForThirdQuarter2016 197
6.19 Oct 25, 2016: Edwards LifesciencesReportsThirdQuarterResults198
6.20 Oct 24, 2016: BostonScientificannouncedkeyPresentationson LotusValve Systemat
TranscatheterCardiovascularTherapeutics2016 200
6.21 Oct 19, 2016: St. Jude Medical ReportsThirdQuarter 2016 Results201
6.22 Oct 14, 2016: AorTechInternational AnnouncesBoardChanges202
6.23 Oct 10, 2016: ProfessorIanMeredithToJoinBostonScientificAsExecutiveVice PresidentAnd
Global Chief Medical Officer203
6.24 Sep19, 2016: BostonScientificReceivesCEMark For LOTUS Edge Valve System203
6.25 Sep19, 2016: Edwards Sapien3TranscatheterHeart Valve ReceivesExpandedIndicationInEurope
204
6.26 Sep19, 2016: VenusMedtech'sTranscatheter PulmonaryValve DebutsinEurope,Markingthe Start
of Global Clinical Trial 204
6.27 Sep16, 2016: FEops ElectsRobMichielsasChairman205
6.28 Sep15, 2016: MedtronicNamesMark Ploof SeniorVice Presidentof Global Operationsand
BusinessServices205
6.29 Sep13, 2016: Colibri HeartValve andVenusMedtechtoFormJointVenture 206
6.30 Sep13, 2016: Colibri HeartValve RaisesAdditional FundsthroughSeriesCFinancing206
6.31 Aug 30, 2016: MPSC Announces2016 InterimResults207
6.32 Aug 26, 2016: VitaFlowGrantedCFDA Green-Path208
6.33 Aug 25, 2016: MedtronicReportsFirstQuarterFinancial Results208
6.34 Aug 25, 2016: CelyadReportsFirstHalf 2016 Financial ResultsandOperational Progress211
6.35 Aug 19, 2016: NorthwesternMedicineFirstinIllinoistoPerformTAVRProcedure onLow-Risk
Patient212
6.36 Aug 18, 2016: FDA approvesexpandedindicationforEdwardsSapienXTTranscatheterHeartValve
214

9. 6.37 Aug 18, 2016: FDA approvesexpandedindicationforEdwardsSAPIEN 3TranscatheterHeart Valve
214
6.38 Aug 15, 2016: AorTechInternational:Auditedresultsforthe yearended31 March 2016 215
6.39 Aug 09, 2016: NeovascReportsSecondQuarterResultsfor2016 217
6.40 Aug 08, 2016: ThubrikarAorticValve EntersintoLicensingAgreementwith WideLine 220
6.41 Aug 01, 2016: MedtronicCoreValveEvolutRSystemFirstTAVItoReceive CEMark forIntermediate
RiskAorticStenosisPatients221
6.42 Jul 28, 2016: BostonScientificAnnouncesResultsForSecondQuarter2016 221
6.43 Jul 27, 2016: Edwards ReceivesApproval ForSAPIEN 3Heart Valve InCanada223
6.44 Jul 26, 2016: Edwards LifesciencesReportsSecondQuarterResults223
6.45 Jul 20, 2016: St. Jude Medical ReportsSecondQuarter2016 Results225
6.46 Jul 13, 2016: BostonScientificElects YoshiakiFujimori toBoardof Directors226
6.47 Jul 08, 2016: UTHealth Structural Heart ProgramteamlauncheslatestTAVRtrial 227
6.48 Jul 08, 2016: NewClinical Trial InvestigatesMinimallyInvasiveTreatmentOptionforAorticStenosis
PatientsWitha Larger Valve Size 227
6.49 Jul 05, 2016: NeovascReceivesNASDAQNotificationRegardingMinimumBidRequirements228
7 Appendix254
7.1 Methodology254
7.2 AboutGlobalData257
7.3 Contact Us 257
7.4 Disclaimer257